Myo-inositol soft gel capsules may prevent the risk of coffee-induced neural tube defects

Bibliography

• Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 2006;7(9):724-31
   PubMed Web of Science ®Google Scholar
• Tinker SC, Hamner HC, Berry RJ, Does obesity modify the association of supplemental folic acid with folate status among nonpregnant women of childbearing age in the United States? Birth Defects Res A Clin Mol Teratol 2012
   Web of Science ®Google Scholar
• Wang Y, Lian L, Golden JA, PIP5KI gamma is required for cardiovascular and neuronal development. Proc Natl Acad Sci USA 2007;104(28):11748-53
   PubMed Web of Science ®Google Scholar
• Majerus PW, Wilson DB, Zhang C, Expression of inositol 1,3,4-trisphosphate 5/6-kinase (ITPK1) and its role in neural tube defects. Adv Enzyme Regul 2010;50(1):365-72
   PubMedGoogle Scholar
• Wilson MP, Hugge C, Bielinska M, Neural tube defects in mice with reduced levels of inositol 1,3,4-trisphosphate 5/6-kinase. Proc Natl Acad Sci USA 2009;106(24):9831-5
   PubMed Web of Science ®Google Scholar
• De Castro SC, Leung KY, Savery D, Neural tube defects induced by folate deficiency in mutant curly tail (Grhl3) embryos are associated with alteration in folate one-carbon metabolism but are unlikely to result from diminished methylation. Birth Defects Res A Clin Mol Teratol 2010;88(8):612-18
   PubMed Web of Science ®Google Scholar
• Greene ND, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 1997;3(1):60-6
   PubMed Web of Science ®Google Scholar
• Reece EA, Khandelwal M, Wu YK, Borenstein M. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol 1997;176(3):536-9
   PubMed Web of Science ®Google Scholar
• Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev 2002;60(3):80-7
   PubMed Web of Science ®Google Scholar
• Groenen PM, Peer PG, Wevers RA, Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 2003;189(6):1713-19
   PubMed Web of Science ®Google Scholar
• Groenen PM, Wevers RA, Janssen FS, Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls? Early Hum Dev 2003;71(1):1-8
   PubMed Web of Science ®Google Scholar
• Cavalli P, Tedoldi S, Riboli B. Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs. Birth Defects Res A Clin Mol Teratol 2008;82(7):540-2
   PubMed Web of Science ®Google Scholar
• Cavalli P, Tonni G, Grosso E, Poggiani C. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. Birth Defects Res A Clin Mol Teratol 2011;91(11):962-5
   PubMed Web of Science ®Google Scholar
• Cavalli P, Cavallari U, Unfer V, Tonni G. Caffeine intake and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol 2011;91(1):67
   PubMed Web of Science ®Google Scholar
• Schmidt RJ, Romitti PA, Burns TL, Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol 2009;85(11):879-89
   PubMed Web of Science ®Google Scholar
• CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 2008;337:a2332
   PubMed Web of Science ®Google Scholar
• Schmidt RJ, Romitti PA, Burns TL, Caffeine, selected metabolic gene variants, and risk for neural tube defects. Birth Defects Res A Clin Mol Teratol 2010;88(7):560-9
   PubMed Web of Science ®Google Scholar
• Bezprozvanny I, Bezprozvannaya S, Ehrlich BE. Caffeine-induced inhibition of inositol(1,4,5)-trisphosphate-gated calcium channels from cerebellum. Mol Biol Cell 1994;5(1):97-103
   PubMed Web of Science ®Google Scholar
• Hume JR, McAllister CE, Wilson SM. Caffeine inhibits InsP3 responses and capacitative calcium entry in canine pulmonary arterial smooth muscle cells. Vascul Pharmacol 2009;50(3-4):89-97
   PubMed Web of Science ®Google Scholar
• Berkowitz BA, Spector S, Pool W. The interaction of caffeine, theophylline and theobromine with monoamine oxidase inhibitors. Eur J Pharmacol 1971;16(3):315-21
   PubMed Web of Science ®Google Scholar
• Lasswell WL Jr, Weber SS, Wilkins JM. In vitro interaction of neuroleptics and tricylic antidepressants with coffee, tea, and gallotannic acid. J Pharm Sci 1984;73(8):1056-8
   PubMed Web of Science ®Google Scholar
• Morck TA, Lynch SR, Cook JD. Inhibition of food iron absorption by coffee. Am J Clin Nutr 1983;37(3):416-20
   PubMed Web of Science ®Google Scholar
• Benvenga S, Bartolone L, Pappalardo MA, Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid 2008;18(3):293-301
   PubMed Web of Science ®Google Scholar
• Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001;358(9298):2069-73
   PubMed Web of Science ®Google Scholar
• Cavalli P, Copp AJ. Inositol and folate resistant neural tube defects. J Med Genet 2002;39(2):E5
   PubMedGoogle Scholar
• Heseker HB, Mason JB, Selhub J, Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr 2009;102(2):173-80
   PubMed Web of Science ®Google Scholar
• Copp AJ, Greene ND. Genetics and development of neural tube defects. J Pathol 2010;220(2):217-30
   PubMed Web of Science ®Google Scholar
• Cockroft DL.. Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology 1988;38(3):281-90
   PubMedGoogle Scholar
• Seller MJ.. Vitamins, folic acid and the cause and prevention of neural tube defects. Ciba Found Symp 1994;181:161-73; discussion 73-9
   PubMedGoogle Scholar
• Harris MJ, Juriloff DM. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 2010;88(8):653-69
   PubMed Web of Science ®Google Scholar
• Wilson KL, Sullivan KM, Wiese C. Inositol 1,4,5-trisphosphate receptor activation and nuclear envelope assembly. Soc Gen Physiol Ser 1996;51:189-93
   PubMedGoogle Scholar
• Cogram P, Hynes A, Dunlevy LP, Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol. Hum Mol Genet 2004;13(1):7-14
   PubMed Web of Science ®Google Scholar
• Platt LD, Golde SH. Neural tube defects in infants of diabetic mothers. Am J Obstet Gynecol 1983;145(3):384-6
   PubMed Web of Science ®Google Scholar
• Goto MP, Goldman AS. Diabetic embryopathy. Curr Opin Pediatr 1994;6(4):486-91
   PubMedGoogle Scholar
• Belmaker RH, Bersudsky Y, Benjamin J, Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry. Adv Biochem Psychopharmacol 1995;49:67-84
   PubMedGoogle Scholar
• Colodny L, Hoffman RL. Inositol--clinical applications for exogenous use. Altern Med Rev 1998;3(6):432-47
   PubMedGoogle Scholar
• Howlett A, Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2003(4):CD000366
   Google Scholar
• Levine J.. Controlled trials of inositol in psychiatry. Eur Neuropsychopharmacol 1997;May7(2):147-55
   PubMed Web of Science ®Google Scholar
• Palatnik A, Frolov K, Fux M, Benjamin J. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol 2001;21(3):335-9
   PubMed Web of Science ®Google Scholar
• Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci 2010;14(6):555-61
   PubMed Web of Science ®Google Scholar
• Papaleo E, Unfer V, Baillargeon JP, Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril 2009;91(5):1750-4
   PubMed Web of Science ®Google Scholar
• De Marco P, Merello E, Cama A, Human neural tube defects: genetic causes and prevention. Biofactors 2011;37(4):261-8
   PubMed Web of Science ®Google Scholar
• Urgert R, van Vliet T, Zock PL, Katan MB. Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers. Am J Clin Nutr 2000;72(5):1107-10
   PubMed Web of Science ®Google Scholar
• Steegers-Theunissen RP, Boers GH, Trijbels FJ, Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 1994;43(12):1475-80
   PubMed Web of Science ®Google Scholar
• Fedrick J.. Anencephalus and maternal tea drinking: evidence for a possible association. Proc R Soc Med 1974;67(5):356-60
   PubMedGoogle Scholar
• Kurppa K, Holmberg PC, Kuosma E, Saxen L. Coffee consumption during pregnancy and selected congenital malformations: a nationwide case-control study. Am J Public Health 1983;73(12):1397-9
   PubMed Web of Science ®Google Scholar
• Linn S, Schoenbaum SC, Monson RR, No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med 1982;306(3):141-5
   PubMed Web of Science ®Google Scholar
• Olsen J, Overvad K, Frische G. Coffee consumption, birthweight, and reproductive failures. Epidemiology 1991;2(5):370-4
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Mitchell AA, Shapiro S, Slone D. Selected birth defects in relation to caffeine-containing beverages. JAMA 1982;12247(10):1429-32
   PubMed Web of Science ®Google Scholar
• Wilkinson JM, Pollard I. In utero exposure to caffeine causes delayed neural tube closure in rat embryos. Teratog Carcinog Mutagen 1994;14(5):205-11
   PubMedGoogle Scholar
• Ross CP, Persaud TV. Neural tube defects in early rat embryos following maternal treatment with ethanol and caffeine. Anat Anz 1989;169(4):247-52
   PubMedGoogle Scholar